Pricing
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (15)
Unverified
3 people · 0 jobs
2 people · 0 jobs
HQ
Tango Therapeutics
3 followers
Cellares
5 followers
Gilead Sciences
188 followers
Regeneron
156 followers
Illumina
85 followers
Agilent Technologies
94 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
51 followers
GRAIL
34 followers
Cytiva
21 followers
PerkinElmer
13 followers
View more